Context Therapeutics Appoints Chief Medical Officer and Vice President of Clinical Operations
PremiumPress ReleasesContext Therapeutics Appoints Chief Medical Officer and Vice President of Clinical Operations
2M ago
Context Therapeutics Acquires CT-95 for Cancer Trial Launch
Premium
Company Announcements
Context Therapeutics Acquires CT-95 for Cancer Trial Launch
2M ago
Context Therapeutics Acquires Phase 1-ready T cell Engager CT-95
Premium
Press Releases
Context Therapeutics Acquires Phase 1-ready T cell Engager CT-95
2M ago
Context Therapeutics Reports First Quarter 2024 Operating and Financial Results
PremiumPress ReleasesContext Therapeutics Reports First Quarter 2024 Operating and Financial Results
4M ago
Context Therapeutics Secures Funding, Advances Clinical Trials
Premium
Company Announcements
Context Therapeutics Secures Funding, Advances Clinical Trials
5M ago
Context Therapeutics to sell 64.5M shares at $1.55 in private placement
Premium
The Fly
Context Therapeutics to sell 64.5M shares at $1.55 in private placement
5M ago
Context Therapeutics submits IND application for CTIM-76
PremiumThe FlyContext Therapeutics submits IND application for CTIM-76
6M ago
Context Therapeutics Reports Full Year 2023 Operating and Financial Results
Premium
Press Releases
Context Therapeutics Reports Full Year 2023 Operating and Financial Results
6M ago
Context Therapeutics expects cash to fund operations into late 2024
Premium
The Fly
Context Therapeutics expects cash to fund operations into late 2024
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100